AllNewsPhotosVideos
Bharat Biotech International

Bharat Biotech

Bharat biotech, Latest News

Bharat Biotech cancels contracts with 2 Brazil firms for Covaxin - Hindi News | Bharat Biotech cancels contracts with 2 Brazil firms for Covaxin | Latest national News at Lokmatnews.in

National :Bharat Biotech cancels contracts with 2 Brazil firms for Covaxin

Bharat Biotech on Friday said it has terminated agreements it had signed with two Brazilian companies - Precisa Medicamentos and Envixia Pharmaceuticals LLC to introduce its Covid-19 Covaxin in Brazil. ...

COVID-19: Second dose trial of Covaxin on 2-6 years to begin by next week - Hindi News | COVID-19: Second dose trial of Covaxin on 2-6 years to begin by next week | Latest national News at Lokmatnews.in

National :COVID-19: Second dose trial of Covaxin on 2-6 years to begin by next week

As part of its COVID-19 vaccination trials for children, Bharat Biotech is likely to administer the second dose of Covaxin to children aged between 2 and 6 years next week, sources said on Thursday. ...

Zydus Cadila expected to provide additional data on Covid-19 vaccine to DCGI this week - Hindi News | Zydus Cadila expected to provide additional data on Covid-19 vaccine to DCGI this week | Latest national News at Lokmatnews.in

National :Zydus Cadila expected to provide additional data on Covid-19 vaccine to DCGI this week

Emergency approval for Zydus Cadila's Covid-19 vaccine may take a few more days with the Ahmedabad-based pharma company set to submit additional data related to immunogenicity and safety of its Zycov-D vaccine to the Drugs Controller General of India ...

Bharat Biotech dossier under review for Covaxin emergency use listing: WHO - Hindi News | Bharat Biotech dossier under review for Covaxin emergency use listing: WHO | Latest national News at Lokmatnews.in

National :Bharat Biotech dossier under review for Covaxin emergency use listing: WHO

Officials of the World Health Organisation (WHO) had a meeting with those of Bharat Biotech and the Hyderabad-based vaccine maker's dossier for Emergency Use Listing (EUL) of Covaxin is under review by the technical experts for consideration, Dr Poon ...

Will receive EUL for Covaxin from WHO at earliest, says Bharat Biotech - Hindi News | Will receive EUL for Covaxin from WHO at earliest, says Bharat Biotech | Latest national News at Lokmatnews.in

National :Will receive EUL for Covaxin from WHO at earliest, says Bharat Biotech

With a review process of 'Covaxin', the indigenous vaccine against COVID-19 commencing at the World Health Organisation (WHO), the Hyderabad-based Bharat Biotech on Monday said it expects to receive emergency use listing (EUL) from the global body at ...

Review process begins for WHO listing of Covaxin: Bharat Biotech - Hindi News | Review process begins for WHO listing of Covaxin: Bharat Biotech | Latest health News at Lokmatnews.in

Health :Review process begins for WHO listing of Covaxin: Bharat Biotech

Hyderabad, July 12 Bharat Biotech on Monday said that it has submitted all documents to the World Health ... ...

EUL to Covaxin from WHO expected in first week of August: Sources - Hindi News | EUL to Covaxin from WHO expected in first week of August: Sources | Latest international News at Lokmatnews.in

International :EUL to Covaxin from WHO expected in first week of August: Sources

The World Health Organisation (WHO) is likely to take a decision on Emergency Use Listing (EUL) of Bharat Biotech's Covaxin and announce it in the first week of August. ...

WHO to take decision on EUL of Covaxin in first week of August - Hindi News | WHO to take decision on EUL of Covaxin in first week of August | Latest national News at Lokmatnews.in

National :WHO to take decision on EUL of Covaxin in first week of August

The World Health Organization's (WHO) is likely to take decision on Emergency use Listing (EUL) of Bharat Biotech's COVID-19 ... ...

After release of Covaxin's phase 3 efficacy data, NTAGI chief says it will help vaccine get WHO recognition - Hindi News | After release of Covaxin's phase 3 efficacy data, NTAGI chief says it will help vaccine get WHO recognition | Latest national News at Lokmatnews.in

National :After release of Covaxin's phase 3 efficacy data, NTAGI chief says it will help vaccine get WHO recognition

Hours after Bharat Biotech announced that its vaccine Covaxin's efficacy against COVID-19 is 77.8 per cent, National Technical Advisory Group on Immunisation (NTAGI) Chief Dr NK Arora said that these results will help the vaccine get recognition from ...

Final Phase-3 results of Covaxin show efficacy of 77.8% against Covid - Hindi News | Final Phase-3 results of Covaxin show efficacy of 77.8% against Covid | Latest health News at Lokmatnews.in

Health :Final Phase-3 results of Covaxin show efficacy of 77.8% against Covid

New Delhi, July 3 Efficacy analysis demonstrates Covaxin to be 77.8 per cent effective against symptomatic COVID-19, through ... ...